chronic colitis
Conditions
Interventions
Healthy control group:Detection of sensitization
Chronic colitis observation group:Detection of sensitization
Sponsors
Shaanxi University of Chinese Medicine
Eligibility
Sex/Gender
All
Age
15 Years to 65 Years
Inclusion criteria
Inclusion criteria: Chronic colitis observation group:1) Meet the diagnostic criteria of chronic colitis;2) Sex is not limited, age between 18-65 years old;3) Those who are willing to participate in the trial and sign the informed consent. Healthy control group:1) No chronic colitis and other digestive diseases;2) Sex is not limited, age between 18-65 years old;3) Those who are willing to participate in the trial and sign the informed consent.
Exclusion criteria
Exclusion criteria: Chronic colitis observation group: 1) does not meet the diagnostic criteria and inclusion criteria; 2) previous myocardial infarction, severe heart failure, valvular heart disease, severe arrhythmia primary cardiomyopathy, blood diseases and other serious cerebrovascular disease; 3) pregnancy, breastfeeding women and psychiatric disorders can not be cooperated with; 4) combined with intestinal tuberculosis, bacillary dysentery, malignant tumors; 5) with fever symptoms affecting thermal probe; 6) patients with skin diseases affecting shape sensitive probe; 7) patients with musculoskeletal diseases causing pain and affecting pain sensitive probe; 8) also participate in other patients with Patients with fever symptoms affecting the heat sensitivity test; Healthy control group: 1) myocardial infarction, severe heart failure, valvular heart disease, severe arrhythmias, primary cardiomyopathy, blood diseases and other serious cerebrovascular disease; 2) pregnancy, lactation and mental illness can not cooperate with the patient; 3) combined with intestinal tuberculosis, bacterial dysentery, malignant tumors; 4) with fever symptoms affecting thermal sensitivity test; 5) patients with dermatologic diseases affecting shape sensitivity test; 6) patients with musculoskeletal diseases causing pain and affecting pain sensitivity test; 7) patients who also participate in other clinical trials.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Skin morphological changes;Skin temperature;Pressure pain threshold; | — |
Countries
China
Contacts
Public ContactQIAO Haifa
Shaanxi University of Chinese Medicine
Outcome results
None listed